AMC Entertainment Holdings, Inc. (“AMC” or “the Company”), one of the
world’s leading theatrical exhibition companies and an industry leader
in innovation and operational excellence, today reported results for the
third quarter, which ended September 30, 2014.
Sign-up for Paragon Shipping Announces The Delivery Of Its First Two Ultramax Newbuildings And Third Quarter And Nine Months Ended September 30, 2014 Results Release Date, Conference Call And Webcast investment picks
- Net income of $1.42 million or $0.38 per diluted share for the quarter - Net income growth of 24.7% YTD; $3.65 million versus $2.93 million for 2013
- Nonperforming assets declined 45% from a year ago; currently represent only 0.62% of total assets WARRENTON, Va.
Corporation (NYSE:ROG) today announced results for the third quarter
of 2014, reporting all-time record net sales of $163.1 million and net
income from continuing operations of $1.09 per diluted share.
Sign-up for Kimco Realty Reports Strong Third Quarter 2014 Operating Results - FFO as Adjusted per Diluted Share Increases 9.1% Led by Solid U.S. Same-Property NOI Growth of 4.9%; Board Approves a 6.7% Dividend Increase per Common Share investment picks
The Law Offices of Vincent Wong are investigating potential claims
against the Board of Directors of BTU International, Inc. (Nasdaq: BTUI)
(“BTU”) in connection with the sale of the Company to Amtech Systems,
Click here to learn about the case: http://docs.wongesq.com/BTUI-Info-Request-Form-443 .
Sign-up for INVESTOR ALERT: The Law Offices of Vincent Wong Investigates the Board of Directors of BTU International, Inc. Regarding the Fairness of the Sale of the Company to Amtech Systems, Inc. investment picks
Global Professionals (“RGP”), the operating subsidiary of Resources
Connection, Inc. (NASDAQ: RECN), announced today that its Board of
Directors has approved an $0.08 per share cash dividend, payable on
December 18, 2014 to all shareholders of record on November 20, 2014.
Focusing development on rare autoimmune disorder IgG4-related disease (IgG4-RD) Ongoing Phase 1b/2a clinical trial on track to report topline results by end of 2014
Conference call today at 5:00 p.m. EDT MONROVIA, Calif.
HILDEN , Germany and TOKYO , October 28, 2014 /PRNewswire/ --
First two programs aim to create tests to aid in cancer treatment with Astellas compounds under development QIAGEN Personalized Healthcare pipeline expands with novel assay targeting FGFR mutations Partnership provides options for collaboration across therapeutic areas, sample types and testing technologies QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced a master collaboration agreement with Astellas Pharma Inc., an R&D-driven global pharmaceutical company headquartered in Japan , to develop and commercialize companion diagnostics paired with Astellas drugs for use in cancer and other diseases.
SANTA CRUZ, CA--(Marketwired - October 28, 2014) - Plantronics, Inc. (NYSE: PLT) today announced second quarter fiscal year 2015 results.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.